Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

251
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
251
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

404
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
404
Clinical Trials01:16

Clinical Trials

10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.4K
Random Error01:04

Random Error

9.8K
Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...
9.8K
Random Variables01:09

Random Variables

17.8K
A random variable is a single numerical value that indicates the outcome of a procedure. The concept of random variables is fundamental to the probability theory and was introduced by a Russian mathematician, Pafnuty Chebyshev, in the mid-nineteenth century.
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
17.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteers.

British journal of clinical pharmacology·2026
Same author

The Evolving Epidemiology of Invasive Pneumococcal Disease in Australian Children: A Multicentre Retrospective Observational Study.

Open forum infectious diseases·2026
Same author

Effectiveness of peer support interventions to improve mental health outcomes after miscarriage: a systematic review and call for high-quality evidence.

BMJ open·2026
Same author

Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia.

The New England journal of medicine·2026
Same author

Tobramycin pharmacokinetic and pharmacodynamic targets in people with cystic fibrosis.

British journal of clinical pharmacology·2026
Same author

Tacrolimus in Pediatric Solid Organ Transplant Recipients: A Retrospective Cohort Study.

Pediatric transplantation·2026

Related Experiment Video

Updated: Jan 30, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K

Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.

Amanda Gwee1,2,3, Noel Cranswick4,2,3, Brendan McMullan5,6

  • 1Department of Paediatrics, The University of Melbourne, Parkville, Australia; amanda.gwee@rch.org.au.

Pediatrics
|February 1, 2019
PubMed
Summary

Continuous vancomycin infusions (CIV) in young infants achieve target concentrations faster and require lower doses than intermittent infusions (IIV). Both methods showed no significant drug-related adverse effects, making CIV a potentially more effective option.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Related Experiment Videos

Last Updated: Jan 30, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.9K

Area of Science:

  • Neonatal pharmacology
  • Pediatric infectious diseases
  • Clinical pharmacy

Background:

  • Continuous infusions of vancomycin (CIV) in adults offer advantages in achieving therapeutic drug levels and potentially reducing toxicity.
  • The efficacy and safety of CIV versus intermittent vancomycin infusions (IIV) in young infants remain less understood.
  • Optimizing vancomycin dosing in neonates is critical due to their unique pharmacokinetic profiles.

Purpose of the Study:

  • To compare the effectiveness of continuous vancomycin infusions (CIV) versus intermittent vancomycin infusions (IIV) in young infants.
  • To determine which infusion method achieves target vancomycin concentrations at the first steady-state level more efficiently.
  • To compare the incidence of drug-related adverse effects between CIV and IIV in this population.

Main Methods:

  • A multicenter randomized controlled trial was conducted in two tertiary neonatal units.
  • Young infants (0-90 days) requiring vancomycin therapy for at least 48 hours were randomized to either CIV or IIV.
  • The primary outcome was the proportion of infants achieving target vancomycin concentrations at the first steady-state level.

Main Results:

  • Continuous vancomycin infusions (CIV) resulted in a significantly higher proportion of infants achieving target concentrations (85% vs. 41%, P < .001).
  • Fewer dose adjustments were needed with CIV, and the mean daily dose to reach target levels was lower compared to IIV (40.6 vs. 60.6 mg/kg/day, P = .01).
  • No drug-related adverse effects were observed in either the CIV or IIV groups.

Conclusions:

  • Continuous vancomycin infusions (CIV) are more effective than intermittent vancomycin infusions (IIV) in young infants for achieving target drug concentrations earlier.
  • CIV requires lower total daily doses to reach therapeutic vancomycin levels in neonates.
  • Both CIV and IIV demonstrate comparable safety profiles with no drug-related adverse effects in this study population.